ArticleBlood neoplasia2026

Late outcomes after posttransplant cyclophosphamide-based GVHD prophylaxis in patients with AML: an ALWP-EBMT study.

Eduardo Rodríguez-Arbolí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.